What is HC Wainwright’s Forecast for ONCY FY2027 Earnings?
Investment analysts at HC Wainwright boosted their FY2027 EPS estimates for shares of Oncolytics Biotech in a research report ...
Leede Financial Issues Positive Outlook for TSE:ONC Earnings
Equities research analysts at Leede Financial boosted their FY2025 earnings per share (EPS) estimates for shares of ...
Oncolytics Biotech: Continuing To Justify The Negativity
Oncolytics Biotech faces financial struggles and unclear pelareorep efficacy signals. Learn why ONCY stock's risks outweigh ...
Oncolytics price target lowered to $3 from $5 at Maxim
Maxim lowered the firm’s price target on Oncolytics (ONCY) to $3 from $5 and keeps a Buy rating on the shares. The firm is adjusting its model ...
Oncolytics price target lowered to C$5 from C$6 at RBC Capital
RBC Capital lowered the firm’s price target on Oncolytics (ONCY) to C$5 from C$6 and keeps an Outperform rating on the shares.Optimize Your ...
Yahoo Finance2d
Oncolytics Biotech Inc. (ONCY)
Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage company specializing in immunotherapy for oncology, today reported on highlights and financial results for Q4 and year ...
TipRanks on MSN6d
Oncolytics Biotech’s Financial Stability at Risk: Urgent Need for New Financing
Oncolytics Biotech (ONCY) has disclosed a new risk, in the Corporate Activity and Growth category. Oncolytics Biotech faces significant business ...
Monday’s analyst upgrades and downgrades
National Financial analyst Maxim Sytchev thinks negative macroeconomic sentiment has led to a “punitive” valuation for Aecon ...